Award of spectral MD's DHA sttr sequential phase II medical R & D contract for "development of device to enable the assessment of burn severity by artificial intelligence in the military's echelon III…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0081
- Awardee
-
Spectral MD, Inc. UEI XYMKTFCE2XR3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,632,483
Award facts
- Opportunity
-
- HQ003420RADST Solicitation number
- Contract value 100% obligated
- $1,632,483.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75201, USA
- Research
- STTR Phase II
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $549,989 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,082,494 |
About this award
The Defense Health Agency awarded Spectral MD, Inc. a $1.63 million Small Business Technology Transfer (STTR) Phase II contract on July 1, 2021, for the development of an artificial intelligence-enabled device to assess burn severity in military Echelon III care environments. This total small business set-aside contract represents a sequential phase continuation of prior STTR work, with an ultimate completion date of February 27, 2026. Spectral MD specializes in wound imaging and assessment using multispectral imaging technology and predictive analytics algorithms to facilitate faster and more accurate clinical decision-making in burn wound evaluation and treatment planning.
The Defense Health Agency's investment in this technology aligns with the military healthcare system's need for improved diagnostic capabilities in battlefield and combat support hospital settings. Spectral MD's multispectral imaging platform and machine learning algorithms are designed to standardize burn severity assessment and enhance treatment outcomes in resource-constrained forward medical environments where rapid, accurate wound evaluation is critical. This contract builds upon the company's established portfolio of federal awards from the Department of Health and Human Services and the Army, demonstrating proven capability in developing innovative medical imaging solutions for burn care applications within the Department of Defense.
Description
Award of spectral MD's DHA sttr sequential phase II medical R & D contract for "development of device to enable the assessment of burn severity by artificial intelligence in the military's echelon III care environment"
Quick answers
Who was awarded contract W81XWH21C0081?
W81XWH21C0081 was awarded to Spectral MD, Inc. by Defense Health Agency (Department of Defense) on June 22, 2021.
How much is contract W81XWH21C0081 worth?
The government has obligated $1,632,483 on W81XWH21C0081.
Was contract W81XWH21C0081 competed?
The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award